AML with BCR-ABL1 Fusion treated with Imatinib, a Hypomethylating Agent and Venetoclax

por Low, Soon Khai, Nanua, Suparna, Patel, Mehul, Renteria, Anne S
Publicado 2022

Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies

por Ocon, Anthony J., Ocon, Kate E., Battaglia, Jennifer, Low, Soon Khai, Neupane, Niraj, Saeed, Hassan, Jamshed, Saad, Mustafa, S. Shahzad
Publicado 2022